Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 20, 2022

BUY
$412.59 - $563.26 $701,403 - $957,542
1,700 New
1,700 $655,000
Q1 2022

Apr 12, 2022

SELL
$524.57 - $735.42 $1.12 Million - $1.57 Million
-2,136 Closed
0 $0
Q4 2021

Jan 12, 2022

BUY
$708.84 - $794.68 $1.01 Million - $1.13 Million
1,424 Added 200.0%
2,136 $1.44 Million
Q4 2021

Jan 12, 2022

SELL
$708.84 - $794.68 $248,094 - $278,138
-350 Reduced 32.96%
712 $481,000
Q3 2021

Oct 12, 2021

BUY
$657.71 - $825.77 $164,427 - $206,442
250 Added 30.79%
1,062 $767,000
Q1 2021

May 21, 2021

BUY
$547.01 - $662.35 $444,172 - $537,828
812 New
812 $474,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Stonnington Group, LLC Portfolio

Follow Stonnington Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonnington Group, LLC with notifications on news.